'NUTRIGENOMICS' AMONG NEXT-GENERATION APPLICATIONS IN AG BIOTECHNOLOGY
Tracy Sayler
Personalized nutrition based on individual genetics, pharmaceuticals from alfalfa, drought-tolerant plants, and improved bioenergy sources are among the next generation of applications that can be expected from agricultural biotechnology.
Next-generation agbiotech applications in North America were discussed in a symposium held recently in St. Paul, Minn., coordinated by the Minnesota Agri-Growth Council, the University of Minnesota, BIOTECanada, and the Canadian Consulate General. Highlights from the conference:
Nutrigenomics – applying genetic science toward human nutrition and health – can be expected to become more prominent, says Chuck Muscoplat, a U of M College of Medicine faculty member and former Dean of the College of Agriculture. As more is becoming known about how genes and chemicals in food affect the genes and chemicals in the human body, more individualized nutrition for better health can be prescribed.
"The hypothesis is that compounds from food can be studied and developed as modulators of gene expression rather than as simple nutrients for basic nutrition," he says. For example, Muscoplat points out that the addition of folate in the diet of pregnant women is, in essence, altering gene expression in a positive way.
Another example of positively altering gene expression through nutrition is genistein, an isoflavone compound in soybeans. Isoflavones act as antioxidants, and studies show that soy genistein has anti-cancer effects. "Genistein is becoming ‘the rage’ now among nutritionists; I take the supplement myself," Muscoplat says. "If I’m a soybean breeder, today I’m breeding for yield and protein, but what about breeding soybean varieties for genistein content? It’s going to happen, not tomorrow, but it’s going to happen."
Medicago (http://www2.medicago.com/en/) of Ste-Foy, Quebec, is one company that is already in the process of developing biopharmaceuticals from plants. Medicago has four products under early stage development, including vaccines against avian influenza (namely Hemagglutinin and Neuraminidase) and a product that has shown positive results in animal studies for reducing cholesterol levels. The company is developing its biopharmaceuticals using alfalfa plants grown in high-tech greenhouses. Michele Martel is team leader for biomass production at Medicago, responsible for greenhouse production of plants expressing pharmaceutical proteins.
Why Alfalfa? It’s a highly-efficient protein production system, she explains, a perennial plant that does not die after harvesting but grows back to maturity in five weeks, without flowering, sexual crossing, or producing seeds. All new leaves are identical, perfectly natural clones of the ones they replace. Alfalfa can be harvested at least ten times a year for ten years or more, providing 10g of recombinant protein for every square meter of greenhouse space. Greenhouse production ensures a controlled, contained growing environment, says Martel.
Performance Plants (http://www.performanceplants.com/home.html) is another Canadian biotech company, focusing on developing traits for improved stress tolerance. David Dennis is president and CEO of Performance Plants, headquartered in Kingston, Ontario, with a Crop Development Center in Saskatoon, Saskatchewan. The company has conducted four years of successful field trials that demonstrate its Yield Protection Technology™ to be highly effective in preserving yields under conditions of drought stress. The technology protects crops exposed to drought conditions by stimulating early closure of leaf stomata prior to wilting. Just recently, Syngenta entered into a licensing agreement with Performance Plants for development of drought tolerant corn and soybeans using Performance Plants’ Yield Protection Technology.
In a prime example of the evolving marriage of agriculture and energy – or as Pioneer marketing director Russ Sanders puts it, "linking the seed to the energy need" – DuPont-owned Pioneer Hi-Bred International Inc is partnering with BP to develop, produce, and market biofuels. The first product to market from this union will be biobutanol, which is targeted for introduction in 2007 in the United Kingdom as a gasoline bio-component.
Biobutanol is produced from the same agricultural feedstock as ethanol (i.e., corn, wheat, sugar beet, sorghum, cassava, and sugarcane) with similar environmental benefits. It can be easily added to conventional gasoline, due to its low vapor pressure, has an energy content closer to that of gasoline, can be blended with ethanol, and can be blended at higher concentrations than ethanol for use in standard vehicle engines.
Further, unlike existing biofuels, biobutanol is expected to be potentially suitable for pipeline transport; as a result, biobutanol has the potential to be introduced into gasoline quickly, while avoiding the need for additional large-scale supply infrastructure. Existing ethanol capacity can be cost-effectively retrofitted to biobutanol production with minor changes in fermentation and distillation.
A backgrounder on biobutanol can be found online at http://www2.dupont.com/Biofuels/en_US.
Tracy Sayler
Agricultural writer and ISB correspondent
Fargo, N.D.
tsayler@casselton.net
